{
    "id": 18007,
    "fullName": "PTPRK - RSPO3",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "PTPRK-RPSO3 results from the fusion of PTPRK and RSPO3, demonstrating over expression of Rspo3 and activation of the Wnt signaling pathway (PMID: 22895193).",
            "references": [
                {
                    "id": 4597,
                    "pubMedId": 22895193,
                    "title": "Recurrent R-spondin fusions in colon cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22895193"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5796,
        "geneSymbol": "PTPRK",
        "terms": [
            "PTPRK",
            "R-PTP-kappa"
        ]
    },
    "variant": "PTPRK - RSPO3",
    "createDate": "02/15/2016",
    "updateDate": "02/15/2016",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 84870,
                "geneSymbol": "RSPO3",
                "terms": [
                    "RSPO3",
                    "CRISTIN1",
                    "PWTSR",
                    "THSD2"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 4549,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a colon cancer cell line harboring PTPRK-RSPO3 demonstrated inhibition of tumor growth and cell differentiation in xenograft models when treated with ETC-159 (PMID: 26257057).",
            "molecularProfile": {
                "id": 18336,
                "profileName": "PTPRK - RSPO3"
            },
            "therapy": {
                "id": 3534,
                "therapyName": "ETC-159",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4598,
                    "pubMedId": 26257057,
                    "title": "Wnt addiction of genetically defined cancers reversed by PORCN inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26257057"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10690,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, LGK974 inhibited growth of colorectal cancer cell lines harboring PTPRK-RSPO3 fusion in culture, and inhibited tumor growth in cell line xenograft models (PMID: 28100566).",
            "molecularProfile": {
                "id": 18336,
                "profileName": "PTPRK - RSPO3"
            },
            "therapy": {
                "id": 1937,
                "therapyName": "LGK974",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8748,
                    "pubMedId": 28100566,
                    "title": "Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28100566"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10767,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, AXIN1 frameshift mutations G265fs and V835fs resulted in reduced Axin1 protein expression, and confered resistance to LGK974 in colorectal cancer cells harboring PTPRK-RSPO3 in culture (PMID: 28100566).",
            "molecularProfile": {
                "id": 27772,
                "profileName": "PTPRK - RSPO3 AXIN1 G265fs AXIN1 V835fs"
            },
            "therapy": {
                "id": 1937,
                "therapyName": "LGK974",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 8748,
                    "pubMedId": 28100566,
                    "title": "Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28100566"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10768,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, knockdown of Axin1 expression via siRNA rendered colorectal cancer cells harboring PTPRK-RSPO3 resistant to LGK974 in culture (PMID: 28100566).",
            "molecularProfile": {
                "id": 27773,
                "profileName": "PTPRK - RSPO3 AXIN1 dec exp"
            },
            "therapy": {
                "id": 1937,
                "therapyName": "LGK974",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 8748,
                    "pubMedId": 28100566,
                    "title": "Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28100566"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 18336,
            "profileName": "PTPRK - RSPO3",
            "profileTreatmentApproaches": [
                {
                    "id": 8142,
                    "name": "WNT Inhibitor",
                    "profileName": "PTPRK - RSPO3"
                }
            ]
        },
        {
            "id": 27772,
            "profileName": "PTPRK - RSPO3 AXIN1 G265fs AXIN1 V835fs",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 27773,
            "profileName": "PTPRK - RSPO3 AXIN1 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}